Deliver to:

Quick Facts for Vivitra 440mg Injection

Molecule name
Trastuzumab
Therapeutic class
Anti-cancer
Pharmacological class
HER2 inhibitor
Indications
1. Advanced and metastatic breast cancer. 2. Metastatic gastric cancer

Composition of Vivitra 440mg Injection

  • Trastuzumab (440mg)

Uses of Vivitra 440mg Injection

  • Advanced and metastatic breast cancer
  • Metastatic gastric cancer

Side Effects of Vivitra 440mg Injection

  • Heart Problems
  • Allergic reactions
  • Kidney problems
  • Breathing difficulties
  • Fever
  • Visual disturbances
  • Nose bleeds or runny nose
  • Hair loss
  • Dizziness
  • Nail disorders
  • Weight loss
  • Loss of appetite
  • Bruising
  • Dry mouth
  • Liver inflammation
  • Muscle pain
  • Asthma/ lung disorders

Safety Advice for Vivitra 440mg Injection

  • Alcohol (CONSULT YOUR DOCTOR): Inform your doctor if you have a history of allergic reactions to Vivitra 440mg Injection to prevent life-threatening complications.
  • Pregnancy (UNSAFE): Tell your doctor if you have a history of lung disorders or breathing problems before starting treatment.
  • Breast Feeding (UNSAFE): Avoid planning pregnancy and breastfeeding for at least 7 months after the last dose.
  • Driving (UNSAFE): Regularly monitor heart parameters during treatment with Vivitra 440mg Injection, as it may affect heart function.

Vivitra 440mg Injection

ContainsTrastuzumab (440mg)
Prescription Required
Keep Vivitra 440mg Injection out of sight and reach of children. Store between 2˚C and 8˚C.
MRP₹38,871.5682% OFF
₹6,996.88

Inclusive of all taxes

Packaging:1 VIAL OF 20ML Solution
Vivitra 440mg Injection

Free Express Cold-Chain Delivery

Temperature-controlled dispatch across India within 4 to 24 hours.

Manufacturer:ZYDUS CADILA
Licensed Network
Store between 2°C and 8°C (Refrigerated)
Rx Verification
Express Dispatch

Financial Assistance Available

Contact our oncology support team to check your eligibility for manufacturer patient assistance programs (PAP) for Vivitra 440mg Injection.

About this medicine

Vivitra 440mg Injection (Trastuzumab (440mg))is a prescription oncology medicine. Below is educational product information — follow your doctor's advice for dose and use.

Vivitra 440mg Injection consists of Trastuzumab as its active constituent, widely prescribed in the treatment of HER2-positive breast cancer. In such cases, the breast cancer cells produce higher levels of HER2 proteins, which promote the rapid growth of cancerous tumors. By targeting these proteins, Vivitra injection helps slow down or stop tumor progression. Apart from breast cancer, This medicine for stomach cancer is also effective in treating metastatic gastric cancer with elevated HER2 protein levels. The This medicine composition is specifically designed to block HER2 activity, thereby improving survival rates in patients. Doctors carefully prescribe the Vivitra injection dosage based on patient condition, body weight, and response to therapy. Patients must strictly follow medical guidance regarding This medicine how to take and adhere to the recommended This medicine dosage for effective results. Like all anticancer drugs, there may be potential risks. This medicine side effects and precautions include monitoring heart health, infusion reactions, and avoiding use during pregnancy or breastfeeding without medical advice. The This medicine for breast cancer and stomach cancer treatment is a valuable targeted therapy option, but its usage requires close medical supervision. Patients are advised to check the Vivitra injection price from reliable sources and consult their oncologist for safe and effective use.

Quick Facts

Molecule nameTrastuzumab
Therapeutic classAnti-cancer
Pharmacological classHER2 inhibitor
Indications1. Advanced and metastatic breast cancer. 2. Metastatic gastric cancer

Generic Name

Trastuzumab (440mg)

Dosage Form

Injection

Prescription Status

Doctor's Rx Required

Uses of Vivitra 440mg Injection

Advanced and metastatic breast cancer
Metastatic gastric cancer

Side Effects of Vivitra 440mg Injection

Oncology medicines should be administered strictly under medical supervision. Inform your oncologist immediately if you experience adverse symptoms.

Heart Problems
Allergic reactions
Kidney problems
Breathing difficulties
Fever
Visual disturbances
Nose bleeds or runny nose
Hair loss
Dizziness
Nail disorders
Weight loss
Loss of appetite
Bruising
Dry mouth
Liver inflammation
Muscle pain
Asthma/ lung disorders

Clinical Safety Advice for Vivitra 440mg Injection

Follow expert clinical guidelines regarding interactions, precautions, and medical conditions when taking Vivitra 440mg Injection.

Alcohol
CONSULT YOUR DOCTOR

Inform your doctor if you have a history of allergic reactions to Vivitra 440mg Injection to prevent life-threatening complications.

Pregnancy
UNSAFE

Tell your doctor if you have a history of lung disorders or breathing problems before starting treatment.

Breast Feeding
UNSAFE

Avoid planning pregnancy and breastfeeding for at least 7 months after the last dose.

Driving
UNSAFE

Regularly monitor heart parameters during treatment with Vivitra 440mg Injection, as it may affect heart function.

Cold-Chain Temperature Protocol

Temperature-controlled cold-chain dispatch for Vivitra 440mg Injection across India, with express delivery in Delhi NCR, Noida, and Ghaziabad.

2°C - 8°C Guaranteed

Temperature Monitoring

Sourced from certified cold-storage warehouses.

Insulated Transit

Dispatched in gel-ice thermal insulated boxes.

Rx Verification

Prescription validated prior to cold dispatch.

Frequently Asked Questions

Clinical Overview: Vivitra 440mg Injection

Vivitra 440mg Injection contains Trastuzumab, a targeted monoclonal antibody. Manufactured by Zydus Lifesciences, it is a trusted, cost-effective biosimilar used primarily to treat HER2-positive breast cancer and HER2-positive metastatic stomach (gastric) cancer.

How It Works (Mechanism of Action)

Some cancer cells make too much of a protein called HER2, which tells the tumor cells to grow and divide rapidly. Vivitra works by seeking out and attaching specifically to these HER2 receptors on the cancer cells. By blocking the receptors, it stops the growth signals and flags the cancer cells so your body's immune system can destroy them.

Therapeutic & Treatment Context

Oncologists prescribe Vivitra for early-stage and metastatic HER2-positive breast cancer, often combined with chemotherapy regimens, as well as for advanced gastric or gastroesophageal junction adenocarcinoma that overexpresses the HER2 protein.

Important Clinical Information & Precautions

Vivitra is a specialized oncology infusion that must be administered by a qualified healthcare professional in a hospital or clinical setting. Because Trastuzumab can occasionally affect heart function, your doctor will check your heart health (such as an echocardiogram or MUGA scan) before and during your treatment course. It is not recommended during pregnancy.

Storage & Safe Handling Instructions

This biologic medicine requires strict cold-chain maintenance. It must be stored in a refrigerator between 2°C and 8°C (36°F to 46°F). Do not freeze or shake the vial. Keep it in its original outer carton to protect it from light until it is ready for preparation.

Dosage & Administration Guidelines

Vivitra is given as an intravenous (IV) infusion. The initial loading dose is typically given over 90 minutes, while subsequent maintenance doses can be administered over 30 minutes if the previous infusions were well tolerated. Your oncologist determines the exact dosing schedule based on your body weight.

Authoritative References & Medical Sources

  • FDA Prescribing Information for Trastuzumab
  • NCCN Clinical Practice Guidelines in Oncology: Breast Cancer

Medical information standards

Educational product information for Vivitra 440mg Injection. Not a substitute for advice from your treating doctor or healthcare provider.

Reviewed by
Nitin Kumar, D.Pharm (UPPC Reg: 63405)Lead Registered Pharmacist · 11 years clinical experience · Drug licence RLF21DL2025001406, RLF20DL2025001420. See our medical review policy.
Content dates
Catalogue copy is re-checked under our editorial standards. Pricing and stock update more often at checkout.
Business address
Vyloo Technologies Pvt. Ltd.
10251, F/F, Library Road, Nawab Ganj, Delhi G.P.O., Delhi, North Delhi- 110006, Delhi, India
GSTIN 07AAKCV0933E1ZF, 09AAKCV0933E1ZB. More on our drug licence page.

Authoritative references

Have questions about your cancer prescription?

Our licensed oncology pharmacists are available to assist with medicine availability, cold-chain handling, and prescription verification.

WhatsAppDidn't find a medicine?Whatsapp Us!